WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax of -$1.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2026-06-30 was -$1.60M, a 172.73% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2026-03-31 was -$1.10M, a 164.71% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-12-31 was -$2.20M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-09-30 was -$1.70M, a 130.91% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2025 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2024 was -$5.80M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2023 was -$4.80M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2022 was -$800.00K.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.60M 10-Q · filed 2026-07-23 | -$2.70M 10-Q · filed 2026-07-23 | -$4.90M derived: sum of 3 quarters · filed 2026-07-23 | -$6.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$1.10M 10-Q · filed 2026-04-23 | -$3.30M derived: sum of 2 quarters · filed 2026-04-23 | -$5.00M derived: sum of 3 quarters · filed 2026-04-23 | -$2.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$3.90M derived: sum of 2 quarters · filed 2026-02-17 | -$1.70M derived: sum of 3 quarters · filed 2026-07-23 | $0.00 10-K · filed 2026-02-17 |
| 2025-09-30 | -$1.70M 10-Q · filed 2025-10-23 | $500.00K derived: sum of 2 quarters · filed 2026-07-23 | $2.20M 10-Q · filed 2025-10-23 | -$2.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $2.20M 10-Q · filed 2026-07-23 | $3.90M 10-Q · filed 2026-07-23 | -$900.00K derived: sum of 3 quarters · filed 2026-07-23 | $4.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $1.70M 10-Q · filed 2026-04-23 | -$3.10M derived: sum of 2 quarters · filed 2026-04-23 | $2.40M derived: sum of 3 quarters · filed 2026-04-23 | -$1.30M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $700.00K derived: sum of 2 quarters · filed 2026-02-17 | -$3.00M derived: sum of 3 quarters · filed 2026-02-17 | -$5.80M 10-K · filed 2026-02-17 |
| 2024-09-30 | $5.50M 10-Q · filed 2025-10-23 | $1.80M derived: sum of 2 quarters · filed 2025-10-23 | -$1.00M 10-Q · filed 2025-10-23 | $700.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$3.70M 10-Q · filed 2025-07-24 | -$6.50M 10-Q · filed 2025-07-24 | -$4.80M derived: sum of 3 quarters · filed 2026-02-17 | -$6.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$2.80M 10-Q · filed 2025-04-24 | -$1.10M derived: sum of 2 quarters · filed 2026-02-17 | -$3.10M derived: sum of 3 quarters · filed 2026-02-17 | |
| 2023-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$300.00K derived: sum of 2 quarters · filed 2026-02-17 | -$4.80M 10-K · filed 2026-02-17 | |
| 2023-09-30 | -$2.00M 10-Q · filed 2024-10-24 | -$6.50M 10-Q · filed 2024-10-24 | ||
| 2022-12-31 | -$800.00K 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |